BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Przybylowska-Sygut K, Stanczyk M, Kusinska R, Kordek R, Majsterek I. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer 2013;13:61-8. [PMID: 23103366 DOI: 10.1016/j.clbc.2012.09.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Abdel Ghafar MT, El-Rashidy MA, Gharib F, Al-Ashmawy GM. Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study. Environ Mol Mutagen 2021;62:399-408. [PMID: 34331480 DOI: 10.1002/em.22456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rajagopal T, Seshachalam A, Rathnam KK, Jothi A, Viswanathan S, Talluri S, Dunna NR. DNA repair genes hOGG1, XRCC1 and ERCC2 polymorphisms and their molecular mapping in breast cancer patients from India. Mol Biol Rep 2020;47:5081-90. [PMID: 32519309 DOI: 10.1007/s11033-020-05577-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Kaur J, Sambyal V, Guleria K, Singh NR, Uppal MS, Manjari M, Sudan M. Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk. Clin Exp Gastroenterol 2020;13:73-86. [PMID: 32214837 DOI: 10.2147/CEG.S232961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Persaud AK, Li J, Johnson JA, Seligson N, Sborov DW, Duah E, Cho YK, Wang D, Phelps MA, Hofmeister CC, Poi MJ. XRCC1‐mediated DNA repair is associated with progression‐free survival of multiple myeloma patients after autologous stem cell transplant. Mol Carcinog 2019;58:2327-39. [DOI: 10.1002/mc.23121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tecza K, Pamula-Pilat J, Lanuszewska J, Grzybowska E. Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2016;7:66790-808. [PMID: 27527855 DOI: 10.18632/oncotarget.11053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
6 Tecza K, Pamula-Pilat J, Lanuszewska J, Butkiewicz D, Grzybowska E. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018;9:9114-36. [PMID: 29507678 DOI: 10.18632/oncotarget.24148] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
7 Qiao L, Feng X, Wang G, Zhou B, Yang Y, Li M. Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls. Oncotarget 2018;9:16220-33. [PMID: 29662639 DOI: 10.18632/oncotarget.23804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Devi KR, Ahmed J, Narain K, Mukherjee K, Majumdar G, Chenkual S, Zonunmawia JC. DNA Repair Mechanism Gene, XRCC1A ( Arg194Trp) but not XRCC3 ( Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case-Control Study in Northeastern Region of India. Technol Cancer Res Treat 2017;16:1150-9. [PMID: 29332455 DOI: 10.1177/1533034617736162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Özgöz A, Hekimler Öztürk K, Yükseltürk A, Şamlı H, Başkan Z, Mutlu İçduygu F, Bacaksız M. Genetic Variations of DNA Repair Genes in Breast Cancer. Pathol Oncol Res 2019;25:107-14. [PMID: 28983784 DOI: 10.1007/s12253-017-0322-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
10 Jalali C, Ghaderi B, Amini S, Abdi M, Roshani D. Association of XRCC1 Trp194 allele with risk of breast cancer, and Ki67 protein status in breast tumor tissues. Saudi Med J 2016;37:624-30. [PMID: 27279507 DOI: 10.15537/Smj.2016.6.13540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Wang L, Xu J, Duan B. Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis. Onco Targets Ther 2017;10:3475-83. [PMID: 28761356 DOI: 10.2147/OTT.S133978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Adampourezare M, Hosseinpourefeizi M, Pouladi N, Hosseinpourefeizi E, Azarfam P. Association of Arg194Trp and Arg399Gln Polymorphisms of XRCC1 Gene and Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients. Int J Cancer Manag 2017;10. [DOI: 10.5812/ijcm.5790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Norjmaa B, Saitoh T, Kasamatsu T, Minato Y, Murakami H. <i>XRCC1</i> Arg194Trp and <i>XRCC1</i> Arg399Gln Polymorphisms Affect Clinical Features and Prognosis of Myelodysplastic Syndromes. kmj 2017;67:93-94. [DOI: 10.2974/kmj.67.93] [Reference Citation Analysis]
14 Huang X, Liu C, Cui Y, Zhang H, Liu Y, Zhou X, Luo J. Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma. Oncol Lett. 2017;13:704-714. [PMID: 28356949 DOI: 10.3892/ol.2016.5496] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
15 Sanjari Moghaddam A, Nazarzadeh M, Noroozi R, Darvish H, Mosavi Jarrahi A. XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature. Iran J Cancer Prev 2016;9:e3467. [PMID: 27366307 DOI: 10.17795/ijcp-3467] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
16 Cuchra M, Mucha B, Markiewicz L, Przybylowska-Sygut K, Pytel D, Jeziorski A, Kordek R, Majsterek I. The role of base excision repair in pathogenesis of breast cancer in the Polish population. Mol Carcinog 2016;55:1899-914. [PMID: 27870262 DOI: 10.1002/mc.22436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
17 Macías-gómez NM, Peralta-leal V, Meza-espinoza JP, Gutiérrez-angulo M, Durán-gonzález J, Ramírez-gonzález JM, Gaspar-del Toro A, Norberto-rodríguez A, Leal-ugarte E. Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population. Familial Cancer 2015;14:349-54. [DOI: 10.1007/s10689-015-9787-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
18 Deng X, Zhang X, Cheng Y, Yang X, Zhao R, Liu X, Li X, Qin C, Lu Q, Yin C. XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C. Tumour Biol 2015;36:4591-6. [PMID: 25616696 DOI: 10.1007/s13277-015-3104-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Norjmaa B, Saitoh T, Kasamatsu T, Minato Y, Murakami H. <I>XRCC1</I> Arg194Trp and <I>XRCC1</I> Arg399Gln Polymorphisms Affect Clinical Features and Prognosis of Myelodysplastic Syndromes. kmj 2015;65:11-19. [DOI: 10.2974/kmj.65.11] [Reference Citation Analysis]
20 Takeshita H, Fujihara J, Yasuda T, Kimura-Kataoka K. Worldwide Distribution of Four SNPs in X-Ray and Repair and Cross-Complementing Group 1 (XRCC1). Clin Transl Sci 2015;8:347-50. [PMID: 25387884 DOI: 10.1111/cts.12237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
21 Zhou Q, Zou BW, Xu Y, Xue JX, Meng MB, Liu FJ, Deng L, Ma DY, Ao R, Lu Y. DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus. Tumour Biol 2015;36:1539-48. [PMID: 25374063 DOI: 10.1007/s13277-014-2718-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
22 Ding P, Yang Y, Cheng L, Zhang X, Cheng L, Li C, Cai J. The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women. PLoS One 2014;9:e92083. [PMID: 24642895 DOI: 10.1371/journal.pone.0092083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
23 Smolarz B, Makowska M, Samulak D, Michalska MM, Mojs E, Wilczak M, Romanowicz H. Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol 2014;35:3495-502. [PMID: 24402573 DOI: 10.1007/s13277-013-1461-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]